Slide background
TAmiRNA – Triple A research and development of RNA diagnostics and therapeutics
Slide background
TAmiRNA – Introducing personalized medicine to Aging
Slide background
TAmiRNA – Harnessing the power of microRNAs for development of innovative diagnostic and therapeutic tools
Slide background
TAmiRNA – Helping to enhance your stability and quality of life with advanced age

r&d grants


FIDELIO aims to train the next generation of scientists in order to tackle the challenges of diabetic bone disease from various angles and with the newest technologies available.



This project has received funding from the Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and innovation programme.

IMI2 project - TransBioLine


The Translational Safety Biomarker Pipeline (TransBioLine) project focus on development of biomarkers of injury for liver, kidney, pancreas, vasculature, central nervous system (CNS) and the development of non-invasive microRNA biomarkers using liquid biopsies. 

Austria Wirtschaftsservice GmbH (AWS)

Seed and Pre-Seed financing of TAmiRNA

Die Österreichische Forschungsförderungsgesellschaft FFG

"Basisprogramm" financing of R&D cooperations of TAmiRNA.


7th Framework Program EU-funded project

The SME Instrument - Horizon 2020

The SME instrument (Horizon 2020) offers seamless business innovation support from idea to market, covering the three stages of the full innovation cycle (proof-of-concept, innovation development and commercialisation).

Logo COST Action

COST Action

This Action aims to create an interdisciplinary network to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.


Click here for your personalized microRNA service offer!